How have conversations around quality of life and side effect management for young breast cancer patients developed?
At the ESMO Breast Cancer Congress 2025 (14–17 May, Munich, Germany) we had the chance to speak with Matteo Lambertini from the University of Genova, to discuss the key insights from the session he co-chaired on survivorship, sex and side effects. Watch the video to find out more about the session, as well as how conversations around genetic counseling, fertility preservation and side effect management for young breast cancer patients have developed.
The opinions expressed in this interview are those of the author and do not necessarily reflect the views of Oncology Central or Taylor & Francis Group.